Wednesday, medical technology company Cyberpunks Inc. (CYBX) reported that its second-quarter net income increased significantly from the previous year quarter.
Cyberonics net income surged to $50.14 million from $8.35 million last year. Earnings per share was $1.73 compared to $0.14 last year.
Results for the quarter included a gain on early extinguishment of debt of $0.6 million and reduction in valuation allowance of $40.4 million. Excluding charges, net income for the quarter increased to $9.06 million from $3.91 million last year. Excluding charges income per share was $0.32 compared to $0.14 last year. An increase of 129% over the prior year.
The company recorded income from operations of $9.1 million, an increase of 101% over the prior year quarter.
On average, six analysts polled by Thomson Reuters expected the company to report profit of $0.20 per share for the quarter. Analysts' estimates typically exclude special items.
Net sales increased 13% to $40.72 million from $36.03 million last year. Analysts expected revenue of $39.85 million for the quarter.
U.S. net product sales attributable to the epilepsy indication increased to an estimated $33.2 million, compared with $28.6 million in the comparable period of fiscal 2009, an increase of $4.6 million, or 16%.
International net sales of $6.8 million increased by $0.3 million from the comparable period of fiscal 2009. International epilepsy unit sales increased by 13% in the second quarter of fiscal 2010. The net sales increase was impacted by a higher percentage of sales being made through distributors. Net income for the six months surged to $58.0 million from $10.4 million last year. Earnings per share for the period was $1.96 for the six months compared to $0.23 for the last year period. Sales for the six months were $79.2 million, a 14% increase from the same period in fiscal 2009.
Cyberonics updated its previously provided guidance range for income from operations from $24.0 million to $27.0 million to $28.0 million to $30.0 million, and increased its guidance range for net sales from $157.0 million-$161.0 million to $159.0 million-$162.0 million.
CYBX closed regular trading on Wednesday at $16.03, up $0.16 or 1.01% on a volume of 0.18 million shares on the Nasdaq, and in the after hour trading the stock price increased to $16.82 up $0.79 or 4.93%.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.